1701615632
1701615633
100. Runeson, B. Mental disorder in youth suicide: DSM-III-R Axes I and II. Acta Psychiatrica Scandinavica79, 490–497 (1989).
1701615634
1701615635
101. Paris, J., and Zweig-Frank, H. A 27-year follow-up of patients with borderline personality disorder. Comprehensive Psychiatry42, 482–487 (2001).
1701615636
1701615637
102. Stone, M. H., Stone, D. K., and Hurt, S. W. Natural history of borderline patients treated by intensive hospitalization. Psychiatric Clinics of North America10, 185–206(1987).
1701615638
1701615639
103. Rosten, N. Marilyn, an untold story. New American Library, New York, 1973.
1701615640
1701615641
104. Gunderson, J. G., Kerr, J., and Englund, D. W. The families of borderlines: A comparative study. Archives of General Psychiatry37, 27–33 (1980).
1701615642
1701615643
105. Frank, H., and Paris, J. Recollections of family experience in borderline patients.Archives of General Psychiatry38, 1031–1034 (1981).
1701615644
1701615645
106. Ogata, S. N., Silk, K. R., Goodrich, S., Lohr, N. E., Westen, D., and Hill, E. M.Childhood sexual and physical abuse in adult patients with borderline personality disorder. American Journal of Psychiatry147, 1008–1013 (1990).
1701615646
1701615647
107. Paris, J., Zweig-Frank, H., and Guzder, J. Risk factors for borderline personality in male outpatients. Journal of Nervous and Mental Disease182, 375–380 (1994).
1701615648
1701615649
108. Zanarini, M. C. Childhood experiences associated with the development of borderline personality disorder. Psychiatric Clinics of North America23, 89–101(2000).
1701615650
1701615651
109. Zweig-Frank, H., Paris, J., and Guzder, J. Psychological risk factors for dissociation and self-mutilation in female patients with borderline personality disorder. Canadian Journal of Psychiatry39, 259–264 (1994).
1701615652
1701615653
110. Yen, S., Zlotnick, C., and Costello, E. Affect regulation in women with borderline personality disorder traits. Journal of Nervous and Mental Disease190, 693–696 (2002).
1701615654
1701615655
111. Bandelow, B., Krause, J., Wedekind, D., Broocks, A., Hajak, G., and Ruther, E.Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with borderline personality disorder and healthy controls. Psychiatry Research134, 169–179 (2005).
1701615656
1701615657
112. New, A. S., Triebwasser, J., and Charney, D. S. The case for shifting borderline personality disorder to Axis I. Biological Psychiatry64, 653–659 (2008).
1701615658
1701615659
113. Paris, J., Nowlis, D., and Brown, R. Developmental factors in the outcome of borderline personality disorder. Comprehensive Psychiatry29, 147–150 (1988).
1701615660
1701615661
114. Bryer, J. B., Nelson, B. A., Miller, J. B., and Krol, P. A. Childhood sexual and physical abuse as factors in adult psychiatric illness. American Journal of Psychiatry144, 1426–1430 (1987).
1701615662
1701615663
115. Soloff, P. H., Price, J. C., Meltzer, C. C., Fabio, A., Frank, G. K., and Kaye, W. H. 5HT2A receptor binding is increased in borderline personality disorder. Biological Psychiatry62, 580–587 (2007).
1701615664
1701615665
116. Snyder, S., and Pitts, W. M. Jr. Electroencephalography of DSM-III borderline personality disorder. Acta Psychiatrica Scandinavica69, 129–134 (1984).
1701615666
1701615667
117. Soloff, P. H., Kelly, T. M., Strotmeyer, S. J., Malone, K. M., and Mann, J. J. Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder. Psychiatry Research119, 11–24 (2003).
1701615668
1701615669
118. Siever, L. J., Buchsbaum, M. S., New, A. S., Spiegel-Cohen, J., Wei, T., Hazlett,E. A., Sevin, E., Nunn, M., and Mitropoulou, V. d,l-fenfluramine response in impulsive personality disorder assessed with [18F] fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology20, 413–423 (1999).
1701615670
1701615671
119. Soloff, P. H., Meltzer, C. C., Greer, P. J., Constantine, D., and Kelly, T. M. A fenfluramine-activated FDG-PET study of borderline personality disorder. Biological Psychiatry47, 540–547 (2000).
1701615672
1701615673
120. Arango, V., Underwood, M. D., Gubbi, A. V., and Mann, J. J. Localized alterations in pre-and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Research688, 121–133 (1995).
1701615674
1701615675
121. Stockmeier, C. A., Dilley, G. E., Shapiro, L. A., Overholser, J. C., Thompson,P. A., and Meltzer, H. Y. Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology16, 162–173 (1997).
1701615676
1701615677
122. Juengling, F. D., Schmahl, C., Hesslinger, B., Ebert, D., Bremner, J. D., Gostomzyk,J., Bohus, M., and Lieb, K. Positron emission tomography in female patients with borderline personality disorder. Journal of Psychiatric Research37, 109–115 (2003).
1701615678
1701615679
123. Herpertz, S. C., Dietrich, T. M., Wenning, B., Krings, T., Erberich, S. G., Willmes,K., Thron, A., and Sass, H. Evidence of abnormal amygdala functioning in borderline personality disorder: A functional MRI study. Biological Psychiatry50, 292–298 (2001).
1701615680
1701615681
124. Donegan, N. H., Sanislow, C. A., Blumberg, H. P., Fulbright, R. K., Lacadie, C.,Skudlarski, P., Gore, J. C., Olson, I. R., McGlashan, T. H., and Wexler, B. E. Amygdala hyperreactivity in borderline personality disorder: Implications for emotional dysregulation. Biological Psychiatry54, 1284–1293 (2003).
[
上一页 ]
[ :1.701615632e+09 ]
[
下一页 ]